JERSEY CITY, N.J. , June 21, 2024 /PRNewswire/ -- InsightAce Analytic Pvt.
Ltd. announces the release of a market assessment report on the " Global Non-Viral Transfection Reagents Market - (Type of Non-Viral Transfection System (Non-Viral Transfection Reagents, Electroporation-based Transfection Systems, Other Non-Viral Transfection Systems), Area of Application (Clinical Applications, Research Applications) By End User (Academic and Research Institutions, Pharmaceutical Companies, Other End-Users)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Non-Viral Transfection Reagents Market is valued at US$ 649.
1 Mn in 2023, and it is expected to reach US$ 1,157.5 Mn by 2031, with a CAGR of 7.7% during the forecast period of 2024-2031.
Transfection, vital for introducing nucleic acids into cells, relies historically on viral vectors but increasingly on non-viral transfection reagents. These chemicals, devoid of viral components, are pivotal in gene therapy, cell-based therapies, and vaccine development due to their safety, ease of use, and adaptability. Request for Free Sample Pages: https://www.
insightaceanalytic.com/request-sample/2533 Lipid-based (e.g.
, lipofectamine), polymer-based (e.g., polyethyleneimine), and nanoparticle-based (e.
g., lipid and polymeric nanoparticles) reagents offer distinct advantages like high transfection efficiency, stability, and controlled release kin.
